"Many New mRNA Applications." This story, by Robert Langreth for Bloomberg Businessweek, explains how Moderna plans to use its mRNA technology to develop shots for influenza, HIV, Zika—and maybe even cancer.

Rebuilding American Prosperity
21:19

Bloomberg Businessweek Weekend - April 3rd, 2026
41:18

Trump Ousts Bondi After Chaotic Tenure at Justice Department
49:20